Transportation, Treasury, Housing And Urban Development, The Judiciary, The District Of Columbia, And Independent Agencies Appropriations Act,
Mr. Chairman, I do not understand the purpose of this amendment. It is designed to restrict information used by the President's Council of Economic Advisers. Just because a Member does not like the findings of an independent study does not…
Mr. Chairman, I do not understand the purpose of this amendment. It is designed to restrict information used by the President's Council of Economic Advisers.
Just because a Member does not like the findings of an independent study does not mean we should be trying to prevent the White House from using that information. What kind of precedent would this set? Where can Congress stop in restricting the President's Council of Economic Advisers and the executive branch from discussing the findings of independent studies? What other type of economic data will Members try to restrict then?
The $800 million figure that the gentleman from Ohio cites is from a 2003 Tufts University study. Is Tufts University no longer able to provide information to this government with studies? Which university will be next? Harvard University? Are they good enough? Princeton? It seems to me Tufts University is a good source of independent information.
This information was put together independently. It was not created out of thin air. It was not created by the White House. The fact is this amount of money that pharmaceutical companies spend on R&D is considerable. They spend enormous resources on research and development. In 2003, pharmaceutical companies spent an estimated $33.2 billion on research and development. In the same year, the budget for the entire NIH, the entire budget for the National Institutes of Health, their operating budget was $27 billion, less than what the industry had spent on R&D alone.
Over the past 10 years, pharmaceutical research companies, scientists and researchers have earned an average of 32 new drug approvals a year. In 2003, a total of 35 new drugs, including 21 new molecular entities and 14 new biologics, were approved by the Food and Drug Administration.
These were important products. These are products used to prevent or treat conditions like Alzheimer's, cancer, HIV infection, asthma, pneumonia, psoriasis, and other infectious diseases. The President's advisers should not be censored while talking about this world-leading American industry and the amount of money that they spend on research and development.
I urge opposition to this amendment.
Mr. Chairman, I reserve the balance of my time.
Mr. Chairman, I yield 1 minute to the gentleman from New Jersey (Mr. Frelinghuysen).
Mr. Chairman, I yield such time as he may consume to the gentleman from Michigan (Mr. Knollenberg).
Mr. Chairman, I reserve the balance of my time.
Mr. Chairman, I yield myself the balance of my time.
Mr. Chairman, it seems that the sponsors of this amendment are intent on impugning the integrity of Tufts University, and that is unfortunate. And they are also intent on censoring the White House and the Council of Economic Advisers of what they can say. Does the gentleman believe that we should apply this message to a President from his party as well? Should the President be unable to reference independent studies on global warming or international labor issues or the minimum wage, or is this really just partisan censorship?
The gentleman uses rhetoric and figures that I may not agree with, but I certainly do not disagree with his right to say it.
This is a bad amendment. I urge its defeat.